Factors Precipitating Or Aggravating Acne
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
United States Patent (19) 11 4,374,125 Newell 45) Feb
United States Patent (19) 11 4,374,125 Newell 45) Feb. 15, 1983 (54) HAIRMOISTURIZING COMPOSITIONS 49-27643 7/1974 Japan ..................................... 424/70 51-20639 6/1976 Japan ..................................... 424/70 75) Inventor: Gerald P. Newell, Hanover Park, Ill. 76-04794 ll/1976 Netherlands ........................ 424/70 73 Assignee: Helene Curtis Industries, Inc., Chicago, Ill. OTHER PUBLICATIONS Drug & Cosmetic Industry, 84(4) at p. 440(t), (1960), (21) Appl. No.: 912,360 Thomsen. (22 Filed: Jun. 5, 1978 Amer. Perfumer and Cosmetics, 78(10), pp. 69-72, (51) Int. Cl......................... A61K 7/06; A61K 47/00 (1963), Burnett, Proteins in Cosmetics. 52 U.S. C. ...................................... 424/70; 424/359; Primary Examiner-Douglas W. Robinson 424/362; 424/365 Attorney, Agent, or Firm-Dressler, Goldsmith, Shore, 58 Field of Search ................... 424/DIG. 2, 70, 362, Sutker & Milnamow, Ltd. 424/365, 359 57 ABSTRACT (56) References Cited An aqueous hair treatment composition for restoring U.S. PATENT DOCUMENTS the proper moisture level in initially moisture deficient 3,235,457 2/1966 Laden .................................... 424/65 hair and maintaining the proper moisture level in hair 3,450,674 6/1969 Walles ..... ... 425/71 initially having a normal moisture content comprising 3,683,939 8/1972 Johnsen ... ... 424/70 from about 0.01 to about 1 weight percent of sodium-2- 3,822,312 7/1974 Sato et al. ............................. 424/70 pyrrolidone-5-carboxylate, from about 0.05 to about 5 3,948,943 4/1976 Eberhardt et al. ................... 424/65 weight percent of glycerin, and from about 0.05 to 4,076,800 2/1978 Marsh et al. -
Personal Care Ingredients Brochure
PERSONAL CARE INGREDIENTS A collection of high-performing esters, ethoxylates, metallic stearates and oleochemicals for use in beauty and personal care applications Hallstar has decades of experience with esterification, a chemistry process that is vital to successful beauty and personal care applications. Combined with expertise in other chemistries through acquisition and partnership, we provide a wide range of proven ingredients. Our strong formulation and production capabilities across product lines enable us to create compelling solutions to customers’ diverse product and technical needs. An ongoing process of invention and Hallstar is a longstanding member of innovation with associated testing the Roundtable on Sustainable Palm continually adds to our base of personal Oil (RSPO) and diligently supports its care chemistry knowledge and our growing principles, goals and efforts to promote library of ingredient performance data. Our sustainable sourcing of palm and palm strong manufacturing capabilities enable kernel oil in its supply chain. As consumer flexible production of both large and small demand for ethical, transparent supply custom volume batches. chains increases, we are committed to supply only RSPO mass balance palm- Hallstar’s broad spectrum of ingredients derived products. Hallstar’s RSPO efforts, is ideal for use in a wide array of toiletries in collaboration with our global suppliers, products such as antiperspirants, bath oils, aim to help maximize the positive impact deodorants, depilatories, hand washes, of palm oil cultivation on the perfumes, shower gels, soaps and shaving communities and environment in palm preparations. Our ingredients are also oil-producing regions. utilized in a diverse array of other leave-on and rinse-off skin care and hair ISO 16128 provides guidelines specific care products. -
BELSIL® | Silicones for the Cosmetics Industry | Product Overview
CREATING TOMORROW’S SOLUTIONS SPECIAL EFFECTS FOR BEAUTY CARE Wacker Chemie AG PERSONAL CARE | BELSIL® Hanns-Seidel-Platz 4 81737 Munich, Germany www.wacker.com/contact SIMPLY BEAUTIFUL: SPECIAL EFFECTS www.wacker.com/belsil Follow us on: FOR THE COSMETICS INDUSTRY The data presented in this brochure are in accordance with the present state of our knowledge but do not absolve the user from carefully checking all supplies immediately on receipt. We reserve the right to alter product constants within the scope of technical 6022e/08.21 supersedes 6022e/03.20 progress or new developments. The recommendations made in this brochure should be checked by preliminary trials because of conditions during processing over which we have no control, especially where other companies’ raw materials are also being used. The information provided by us does not absolve the user from the obligation of investigating the possibility of infringement of third parties’ rights and, if necessary, clarifying the position. Recommendations for use do not constitute a warranty, either express or implied, of the fi tness or suitability of the product for a particular purpose. HAIRCARE EFFECTS Shampoos 10 Conditioners 14 Styling 18 Selection Guide 22 SKINCARE EFFECTS Creams and Lotions 28 Sun-Care Products 32 Shaving Products 36 Selection Guide 40 MAKE-UP EFFECTS Foundations 46 Lips 50 Eyes 54 Nails 58 Selection Guide 62 1 2 SILICONES AS BEAUTY SPECIALISTS: TAKE THE EASY WAY Silicones are genuine beauty specialists. At all levels. They help with personal care, beautify skin and hair, and even make the cosmetic product itself more attractive. For example, they confer smoothness on creams and prevent stickiness in oils. -
Jeechem Ipm Nf 98% (Isopropyl Myristate Nf) Description: Jeechem Ipm Is the Ester of Isopropyl Alcohol and Myristic Acid
24 Madison Road, Fairfield, New Jersey 07004, USA Tel: 800-771-JEEN (5336), Tel: 973-439-1401, Fax: 973-439-1402, email: [email protected] , Website: www.jeen.com JEECHEM IPM NF 98% (ISOPROPYL MYRISTATE NF) DESCRIPTION: JEECHEM IPM IS THE ESTER OF ISOPROPYL ALCOHOL AND MYRISTIC ACID. IT IS A LOW VISCOSITY FLUID EMOLLIENT AND COSOLVENT SUITABLE FOR USE OVER A BROAD PH RANGE. IT IS COMPATIBLE WITH NONIONIC, ANIONIC AND CATIONIC SURFACTANTS. APPLICATION: JEECHEM IPM IS A VERSATILE FORMULATING INGREDIENT FOR COSMETICS, TOILETRIES, AND TOPICAL PHARMACEUTICALS. IT IS A SUPERIOR EMOLLIENT VEHICLE FOR NONGREASY BATH, BODY AND BABY OILS. IT ADDS LUBRICITY TO PRE-ELECTRIC SHAVES, SHAVING CREAMS, BODY POWDERS AND ANTIPERSPIRANTS. IN ANHYDROUS AND EMULSIFIED MAKEUPS, IT ENHANCES THE APPLICATION PROPERTIES BY REDUCING THE DRAG IMPARTED BY THE WAXES AND VISCOUS OILS. IT IS A LUBRICANT AND COMPRESSION AID FOR PRESSED POWDERS. JEECHEM IPM IS A LIGHT NONTACKY EMOLLIENT FOR CREAMS AND LOTIONS. IT IS ESPECIALLY SUGGESTED FOR VANISHING CREAMS AND FOR HAND AND BODY MOISTURIZERS. WHEN USED AT HIGH CONCENTRATIONS IN CLEANSING PREPARATIONS, IT GENTLY LIFTS MAKEUP AND SURFACE DIRT. IT IS A PLASTICIZER FOR HAIR STYLIZING RESINS AND A GLOSSER FOR HAIR GROOMS. SPECIFICATIONS: APPEARANCE @ 25oC: CLEAR, PRACTICALLY ODORLESS OILY LIQUID ACID VALUE 1.0 MAXIMUM IODINE VALUE 1.0 MAXIMUM SAPONIFICATION VALUE: 202 - 212 COLOR (APHA): 30 MAXIMUM SPECIFIC GRAVITY @ 25oC: 0.8460-0.8540 RESIDUE ON IGNITION: 0.10 MAXIMUM REFRACTIVE INDEX @ 20oC: 1.4320-1.4360 MOISTURE %: 0.10 MAXIMUM IDENTIFICATION: POSITIVE ASSAY: 98 % MINIMUM ORGANIC VOLATILE IMPURITIES: CONFORMS SOLUBILITY: JEECHEM IPM IS SOLUBLE IN MINERAL OIL, CASTOR OIL, COTTONSEED OIL AND ETHANOL. -
Mineral Makeup and Its Role with Acne and Rosacea Jane Iredale, MA; Jennifer Linder, MD
REVIEW Mineral Makeup and Its Role With Acne and Rosacea Jane Iredale, MA; Jennifer Linder, MD Rosacea and acne have been the cause of physical and emotional distress for patients worldwide. Part of the distress has originated from the inability to find products that provide coverage without exacerbating the conditions. This includes understanding the role of certain ingredients with their attendant negative and positive effects. Fifteen years of experience has shown that mineral makeup can play a large part in helping to repair patients’ self-esteem as well as playing a meaningful role in skin improvement. IDENTIFYING AUTHENTIC For physicians to assess mineral makeup and its ben- MINERAL MAKEUP efits for their patients with rosacea and acne, it is neces- Patients with acne and rosacea frequently seek options to sary to explore the chemical composition of authentic cover what they consider toCOS be visually frustrating condi- DERMmineral powder. Many makeup brands are now mar- tions. Regrettably, they often make choices that are not keting products they call mineral makeup, but they effective and potentially detrimental to their situation. do not utilize authentic minerals in their formulations. To serve these patients better, physicians should educate The incorrect use of the word mineral as a marketing themselves and their staffs about camouflaging options. term confuses patients and can lead to the use of prod- Mineral makeup can beDo a satisfactory solutionNot as it is a ucts Copythat can potentially worsen their condition due to healthy, skin-friendly alternative to traditional makeup. problematic ingredients. Mineral makeup not only provides superior coverage and The original definition of mineral makeup is a makeup is easy to use, but it is also UV protective, noncomedo- that eliminates talc, potential skin irritants, and comedo- genic, and anti-inflammatory. -
United States Patent (19) 11 Patent Number: 5,994,330 El Khoury (45) Date of Patent: Nov.30, 1999
USOO599433OA United States Patent (19) 11 Patent Number: 5,994,330 El Khoury (45) Date of Patent: Nov.30, 1999 54 TOPICAL APPLICATION OF MUSCARINIC S. Abram, MD et al., Anesth Analg., “Intrathecal Acetyl AGENTS SUCH AS NEOSTIGMNE FOR Cholinesterase Inhibitors Produce Analgesia That is Syner TREATMENT OF ACNE AND OTHER gistic with Morphine and Clonidine in Rats, 81:501-7 NFLAMMATORY CONDITIONS (1995). C. Stein, M.D. et al., New England Journal of Medicine, vol. 76 Inventor: Georges F. El Khoury, 1561 Ramillo 325, No. 16 “Analgesic Effect of Intraarticular Morphine Ave., Long Beach, Calif. 90815 After Arthroscopic Knee Surgery, pp. 1123-1126. T. Yaksh, Ph.D. et al., Anesthesiology, “Studies on the Safety 21 Appl. No.: 09/188,328 of Chronically Administered Intrathecal Neostigmine Meth 22 Filed: Nov. 9, 1998 ylsulfate in Rats and Dogs,” V 82. No. 2, Feb. 1995. “Morphine-A Local Analgesic, International ASSocia (51) Int. Cl." ..................................................... A01N 57/00 tion for the Study of Pain, vol. III. 52 U.S. Cl. .......................... 514/123; 514/123; 514/859; G. Lauretti, MD et al., Anesth Analg “The Effects of 514/855; 514/289; 514/912; 514/78.04; Intrathecal Neostigmine on Somatic and Visceral Pain: 424/401 Improvement by Associate with a Peripheral Anticholin 58 Field of Search ........................... 424/401; 536/55.1; ergic,” 81:615–20 (1996). 514/912, 78.04, 289, 859, 123,855 D. Hood, M.D., et al., Anesthesiology, “Phase I Safety Assessment of Intrathecal Neostigmine Methylsulfate in 56) References Cited Humans,” V 82, No. 2, Feb. 1995 pp. 331-342. U.S. -
(12) United States Patent (10) Patent No.: US 9.486,408 B2 Edelson Et Al
USOO9486408B2 (12) United States Patent (10) Patent No.: US 9.486,408 B2 Edelson et al. (45) Date of Patent: Nov. 8, 2016 (54) BOTULINUM NANOEMULSIONS 5,851,452 A 12/1998 Vallet Mas et al. 5,858.410 A 1/1999 Muller et al. (71) Applicant: UNIVERSITY OF 5,925,341 A 7/1999 Cervantes et al. MASSACHUSETTS LOWELL, 5,932,562 A 8/1999 Ostlund, Jr. Lowell, MA (US) 5,994.414 A 11/1999 Franco et al. 6,007,856 A 12/1999 Cox et al. 6,039,936 A 3/2000 Restle et al. (72) Inventors: Jonathan Edelson, Scarsdale, NY 6,165,500 A 12/2000 Cevc (US); Robert Nicolosi, Nashua, NH 6,224,853 B1 5, 2001 Steel et al. (US) 6,265,180 B1 7/2001 Zuelli et al. 6,274,150 B1 8/2001 Simonnet et al. (73) Assignee: University of Massachusetts Lowell, 6,312,708 B1 1 1/2001 Donovan Lowell, MA (US) 6,358,917 B1 3/2002 Carruthers et al. 6,387.411 B2 5, 2002 Bruce et al. (*) Notice: Subject to any disclaimer, the term of this 6,429,189 B1 8, 2002 Borodic patent is extended or adjusted under 35 6,558,941 B2 5/2003 Zuelli et al. U.S.C. 154(b) by 372 days. 6,573.241 B1 6/2003 Bigalke et al. 6,589,588 B1 7/2003 Wester et al. (21) Appl. No.: 13/647,759 6,623,780 B1 9, 2003 Stevens et al. 6,632.440 B1 10/2003 Quinn et al. -
RE-REVIEW Supplement Book 1 Alkyl Esters CIR EXPERT PANEL
RE-REVIEW Supplement Book 1 Alkyl Esters CIR EXPERT PANEL MEETING MARCH 5-6, 2012 ALKYL ESTERS RE-REVIEW – SUPPLEMENTAL BOOK 1 Cetyl Esters and Other Previously Reviewed Alkyl Esters Cetyl Esters ...................................................................................................................................................... 1 Isopropyl Linoleate .......................................................................................................................................... 9 Cetearyl Octanoate (now Cetearyl Ethylhexanoate) ...................................................................................... 15 Octyl, Cetyl, and Isopropyl Palmitate ............................................................................................................ 25 Decyl and Isodecyl Oleate ............................................................................................................................. 48 Butyl, Cetyl Isobutyl, Isocetyl, Isopropyl, Myristyl, and Octyl Stearate ....................................................... 59 Isostearyl Neopentanoate ............................................................................................................................... 99 Arachidyl Propionate ................................................................................................................................... 121 Isopropyl Isostearate .................................................................................................................................... 131 Cetyl, -
Canadian Clinical Practice Guideline on the Management of Acne (Full Guideline)
Appendix 4 (as supplied by the authors): Canadian Clinical Practice Guideline on the Management of Acne (full guideline) Asai, Y 1, Baibergenova A 2, Dutil M 3, Humphrey S 4, Hull P 5, Lynde C 6, Poulin Y 7, Shear N 8, Tan J 9, Toole J 10, Zip C 11 1. Assistant Professor, Queens University, Kingston, Ontario 2. Private practice, Markham, Ontario 3. Assistant Professor, University of Toronto, Toronto, Ontario 4. Clinical Assistant Professor, University of British Columbia, Vancouver, British Columbia 5. Professor, Dalhousie University, Halifax, Nova Scotia 6. Associate Professor, University of Toronto, Toronto, Ontario 7. Associate Clinical Professor, Laval University, Laval, Quebec 8. Professor, University of Toronto, Toronto, Ontario 9. Adjunct Professor, University of Western Ontario, Windsor, Ontario 10. Professor, University of Manitoba, Winnipeg, Manitoba 11. Clinical Associate Professor, University of Calgary, Calgary, Alberta Appendix to: Asai Y, Baibergenova A, Dutil M, et al. Management of acne: Canadian clinical practice guideline. CMAJ 2015. DOI:10.1503/cmaj.140665. Copyright © 2016 The Author(s) or their employer(s). To receive this resource in an accessible format, please contact us at [email protected]. Contents List of Tables and Figures ............................................................................................................. v I. Introduction ................................................................................................................................ 1 I.1 Is a Clinical Practice Guideline -
A Comprehensive Review of Acne Vulgaris AK Mohiuddin1* 1Department of Pharmacy, World University of Bangladesh
Symbiosis ISSN Online: 2378-1726 www.symbiosisonlinepublishing.com Review Article Clinical Research in Dermatology: Open Access Open Access A Comprehensive Review of Acne Vulgaris AK Mohiuddin1* 1Department of Pharmacy, World University of Bangladesh Received: May 25, 2019; Accepted: June 6, 2019; Published: June 17, 2019 *Corresponding author: AK Mohiuddin, Assistant Professor, Department of Pharmacy, World University of Bangladesh, 151/8, Green Road, Dhanmondi, Dhaka – 1205, Bangladesh. E-mail: [email protected]; Orcid Id: https://orcid.org/0000-0003-1596-9757. Abstract Acne, also known as acne vulgaris (AV), is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin. It is characterized by blackheads or whiteheads, pimples, oily skin, and possible scarring. An intact stratum corneum and barrier, normal natural moisturizing factor and hyaluronic acid levels, normal Aquaporin-3 (AQP3) expression (localized at the basal lateral membranes of collecting duct cells in the kidney), and balanced sebum secretion are qualities of the skin that fall in the middle of the oily–dry spectrum. Patients rarely, if ever, complain about reduced sebum production, but elevated sebum production, yielding oily skin that can be a precursor to acne, is a common Propionibacterium acnes in adolescence, under the complaint. Several factors are known to influence sebum production. AV is mostly triggered by impact,influence as of sebum normal levels circulating are usually dehydroepiandrosterone low in childhood, rise (DHEA). in the middle-to-late It is a very common teen years, skin disorder and remain which stable can presentinto the withseventh inflammatory and eighth and decades non- untilinflammatory endogenous lesions androgen chiefly synthesis on the face dwindles. -
Review on Acne Cosmetica with Management by Vishaghan Mahakashay and Lodhradi Lepa
wjpmr, 2018,4(11), 105-109 SJIF Impact Factor: 4.639 Review Article WORLD JOURNAL OF PHARMACEUTICAL Sharma et al. AND MEDICAL RESEARCH World Journal of Pharmaceutical and Medical ResearchISSN 2455 -3301 www.wjpmr.com WJPMR REVIEW ON ACNE COSMETICA WITH MANAGEMENT BY VISHAGHAN MAHAKASHAY AND LODHRADI LEPA Dr. Kirti Sharma*1, Dr S.R. Inchulkar2 and Dr. Prafulla3 1P.G. Scholar, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College, Raipur (C.G.). 2Professor & HOD, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College Raipur (C.G.). 3Reader, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College, Raipur (C.G.). *Corresponding Author: Dr. Kirti Sharma P.G. Scholar, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College, Raipur (C.G.). Article Received on 09/09/2018 Article Revised on 30/09/2018 Article Accepted on 21/10/2018 ABSTRACT Acne cosmetica is an inflammation of pilosebaceous follicle of certain body areas occurs commonly in 80% adolescence. It is a condition which occurs due to the use of certain makeup and cosmetics products, seen on the skin area where the beauty product is applied. Acne cosmetica was described at the first time by Kligman and Mills in 1972. In Ayurveda Acne cosmetica comes under mukhdushika, Cosmetics and beauty products having various chemical and these are considered as kritrim visha. kritrimavisha (Artificial poisons) is prepared by the combination of various animate, inanimate poisons. Acharya Charak described Vishghna mahakashaya and Acharya Sharangadhara mentioned lodhradi lepa can be a better choice for the treatment of Acne cosmetica or mukhdushika, by its antitoxic effect, blood purification and varnya (skin complexion) property. -
Amended Safety Assessment of Alkyl Esters As Used in Cosmetics
Amended Safety Assessment of Alkyl Esters as Used in Cosmetics Status: Tentative Amended Report for Public Comment Release Date: December 18, 2012 Panel Meeting Date: March 18-19, 2013 All interested persons are provided 60 days from the above release date to comment on this safety assessment and to identify additional published data that should be included or provide unpublished data which can be made public and included. Information may be submitted without identifying the source or the trade name of the cosmetic product containing the ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or requests to the CIR Director, Dr. F. Alan Andersen. The 2012 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D., Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is F. Alan Andersen, Ph.D. This report was prepared by Monice M. Fiume, Senior Scientific Analyst/Writer, and Bart Heldreth, Ph.D., Chemist CIR. Cosmetic Ingredient Review 1101 17th Street, NW, Suite 412 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 ♢ [email protected] TABLE OF CONTENTS Abstract .....................................................................................................................................................................................................................